TLSI 株価分析 — Trisalus Life Sciences Inc. (Healthcare >> Medical Devices)
TLSI に関するよくある質問
TLSIのPER(株価収益率)は?
Trisalus Life Sciences Inc.(TLSI)は現在PER 181.97倍で取引されています。
TLSIのROE(自己資本利益率)は?
Trisalus Life Sciences Inc.のROEは-213.27%です。
TLSIの配当利回りは?
Trisalus Life Sciences Inc.の配当利回りは0.00%です。
TLSIの品質スコア(Quality Score)は?
当社のAIはTLSIの総合財務品質を100点中31点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
TLSIは今が買い時ですか?
当社AIのタイミングスコアは100点中91点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
TLSIはどのセクターに属しますか?
Trisalus Life Sciences Inc.はHealthcare >> Medical Devicesセクターに分類されます(NASDAQ市場)
TLSI AI Analysis Summary
Our AI summary for TLSI: Trisalus Life Sciences Inc. (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 181.97, ROE of -213.27%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 4.54
Price
-0.02
(-0.44%)
Day Change
|
|
|---|
TLSI, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) but テクニカルスコアは ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 86 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 4.54 |
| PBV / Sector |
21.87 / -101.57
|
| Earning Per Share | -0.44 |
| PE / Sector |
181.97 / 31.23
|
| PEG or PE/Growth / Sector |
-26.22 / 0.40
|
| Average 1M Daily Value |
0.91 M
GREAT
|
| Average 1W Daily Value |
0.59 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
56% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:35 |
| Symbol | TLSI |
| Name | TRISALUS LIFE SCIENCES INC. |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 61.42 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 280.06 / 20,104.97 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 6272 West 91st Avenue, Westminster, CO, United States, 80031
Phone: 888 321 5212
Website: https://trisaluslifesci.com
Employees: 102
Sector: Healthcare >> Medical Devices
Description: TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States. It offers Pressure-Enabled Drug Delivery (PEDD) infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial for treating locally advanced pancreatic cancer. The company is also developing nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and pancreatic cancer. It serves interventional radiologists, IR technicians, medical oncologists, nursing support, and value analysis committee staff. The company was founded in 2009 and is headquartered in Westminster, Colorado.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
Google